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Treatment	  of	  TC	  mimics	   the	  treatment	  of	  a	  
non-­‐STEMI
• aspirin
• nitroglycerin	   infusionà vasodilation	   and	  
decreased	  preload/afterload	  
• heparin	   infusion
• Beta-­‐blockers	  àdecrease	  catecholamine	  
stimulation	   and	  cardiac	  demand
• Inotropes	  and	  intra-­‐aortic	  balloon	   pump	  
(IABP)	  àmay	  be	  temporarily	  necessary	  
to	  ensure	  hemodynamic	  stability
• diuretics	  à prevent	  pulmonary	  edema
• anxiolytics	  à such	  as	  lorazepam	  should	  
be	  considered,	  as	   stress	   is	   the	  at	  the	   root	  
of	  TC’s	   pathophysiology
• Stents,	   thrombolytics,	   and	  chronic	  heart	  
disease	   medications	  are	  no	   longer	  
recommended	  for	   the	  treatment	  of	  TC.	  
Nursing	  care	  should	   focus	  on	  education	  on	  
TC’s	   reversibility	   and	  also	   to	   identify	   long-­‐
term	  complications	  such	  as	  cardiogenic	  
shock	  or	   thrombus	   formation	  and	  
subsequent	   CVA	  which	  occur	  from	  the	  
abnormal	  ventricular	  wall	  movement.	  	  
Supporting	   the	  patient	  not	  only	  medically	  
but	  emotionally	  can	  help	  with	  disease	  
progression	   and	   lead	  to	   restoration	   of	  
myocardial	  function.
Takotsubo cardiomyopathy (TC) isa syndrome that was
identified in the early 1990s in Japan toexp lain anacute
coronary syndrome (ACS) presentat ion without the
typicalcoronary artery occlusion that accompanies ACS .
Although rare , Takotsubu cardiomyopathy or broken
heart syndrome, has become a t opic of interest in the
world of cardio logy care. It has st umped the medica l
world with its identical pre sentation to a ST-­‐elevated
myocardial infarction (STEMI),wit h symptomsof angina ,
ST-­‐segment elevation on 12-­‐ lead EKG, elevated
myocardialenzymemarkers, andmoderate t o severe left
ventricular dysfunction without coronary artery
occlusion
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Implications	   for	  Care
Takotsubo cardiomyopathy	  is	  a	  complex	  
condition.	   	  Although	   necessary,	   increased	  
cost,	  patient	   stress,	   and	  superfluous	  
hospital	   resource	  use	  occur	  as	   the	  
condition	  mimics	  acute	  coronary	  syndrome	  
and	  must	  be	   treated	  as	   so	  until	   the	  
diagnosis	   of	  TC	  can	  be	  achieved.	  	  An	  excess	  
in	  catecholamines	  produced	  by	  acute	  
events	  of	  physical	  or	  emotional	   stress	  
seem	  to	  be	  evident	  in	  all	   current	   research,	  
but	  a	  dysfunction	   in	   the	  parasympathetic	  
nervous	  system	  and	  coronary	  vasospasms	  
have	  also	  been	  attributing	   factors.	  	  Quick	  
recognition	  and	   treatment	  with	  aspirin,	  
heparin,	   nitrates,	  beta-­‐blockers,	   possibly	  
IABP,	  as	  well	  as	  vasopressors	   are	  indicated	  
to	   increase	  cardiac	  function,	   to	  enhance	  
end-­‐organ	  perfusion	  and	  prevent	  
cardiogenic	  shock	  as	  well	   as	  thrombus	  
formation.	  	  Emotional	   support	  along	  with	  
anxiolytic	   therapy	  is	   recommended	  
because	  as	   the	  catecholamine	  levels	  
decrease,	   the	  myocardium	  has	  proven	   to	  
restore	   itself	   back	  to	  the	  pre-­‐stressor	   state	  
of	  function.	   	  Healing	  a	  broken	  heart	  may	  be	  
complicated,	  but	  with	  evidence-­‐based	  
treatment	  and	  excellent	  nursing	   care,	  TC	   is	  
entirely	   reversible.	   	  
Conclusion
During great stress , the sympathetic nervou s system is in over-­‐dr ive ,
producing an excess of endogenou s catecholamines l ike epine phrine and
norepinephr ine. The se endogenous chemicals st imulate the Beta-­‐adrenerg ic
cells located in the heart that increase heart rate and contractility and induce
hypertrophy on the cells. This i s seen in the bal loonin g of the left ventricular
apex most common inTC.
Underlying	  Pathophysiology
The significance of the pathophysiology lie s in its exact mimicking
of acute coronary syndrome. Patie nts must be t reated per ACS
protocol and only once coronary angiography confirms there is an
absence of coronary occlusion and crite rion is met can a patient be
diagnosed and treated wit h TC. The under lying pathophysio logy has
not been clearly defined so fu rther research on t he cond ition is highly
warranted. TC is sign ificant in its causative factor be ing endogenous –
although r isk factors suchas hyper lipidemia, smoking ,anda lcohol use
has been identifie d, the inten se catecholamine surge is not a
modifiable factor.
Classic	   signs	  and	  symptoms	  of	  myocardial	  infarction	  
(MI)
• crushing	  sub-­‐sternal	   chest	  pain
• can	  include	   typical	  radiation	   to	  left	  arm,	  back,	  
and	   jaw	  seen	   in	  MI
• elevated	   troponin	   level
• ST-­‐segment	  elevation	  on	  EKG	  (See	  Figure	  1)
• marked	  systolic	  dysfunction	  with	  decreased	  
ejection	   fraction	  (EF)	  via	  echocardiography
• left	  ventricular	  apical	  ballooning	   with	  
hypokinesia of	   the	  myocardium
• absence	  of	  coronary	  artery	  occlusion	  during	  
cardiac	  catheterization
• concurrent	  acute	  physical	  or	  emotional	   stress	  
event
• death	  of	  a	  loved	  one	   is	   typical
• absence	  of	  coronary	  artery	  occlusion	  during	  
cardiac	  catheterization
• myocardial	  dysfunction	   restored	  without	  
intervention	   (i.e. 	  balloon	  angioplasty	  or	  cardiac	  
stent)
Figure	  1:	  Classic	  “fireman’s	  hat”	  ST-­‐segment	  elevation	  
seen	   in	  STEMI	  and	  also	   in	  Takotsubo Cardiomyopathy.
Figure	  2:	  On	  the	  left:	  the	  dilated	  ballooning	  of	  the	  left	  ventricular	  apex	  classically	  seen	  in	  Takotubo cardiomyopathy.	  	  On	  
the	  right:	  the	  Japanese	  pot	  in	  which	  Takotsubu cardiomyopathy	  was	  named	  after.	  	  “Tako”	  meaning	  octopus	  and	  “tsubo”	  
meaning	  pot.	  	  Notice	  the	  narrowed	  neck	  with	  enlarged	  base	  of	  the	  pot.	  
Significance	  of	  Pathophysiology
Massive	  Catecholamine	  Release
Left	  Ventricular	  Apical	  Ballooning
The term tako-­‐tsubo ,a Japanese term,“describesa narrow neck fishing pot
used to catchoctopus” (see Figu re 2). Th is narrow neck andbowed out ba se of
the pot are characteristic of the left ventr icle ballooning out dur ing TC. The
apex is saturated with Beta-­‐adrenergic receptor s and dur ing ep isode s of
catecholamine excess, i s be lieved to be in hyper-­‐drive and attribute s to the
exaggerated shape, left ventricular dysfunction , and leaking of tr oponin , which
is a manifestation of myocardial damage. This hypertrophy is be lieved to
induce increased filling pressures and cause a significant decrease in the EF.
Surges of epinephrine during intense per iods of phy sical or emotional stress
also collect in the coronary arterie s and bel ieve to cause vasospasm s of the
coronary vasculature, causing myocardial i schemia and the ST-­‐segment
elevation classical ly identifie d during STEMI (ST elevated myocardial
infarction) andTC.
Coronary	   Artery	  Vasospasms
Parasympathetic	  Dysfunction
Norcliffe-­‐Kaufmann et al., (2016) introduce their finding s that participants in
their study had a para sympathetic dysfunction t hat led to prolonged period s
of sympathetic stimu lation after stre ss that contributed to the ir
cardiomyopathy. Without the typical ”rest and dige st” function of the
parasympathetic nervous system, the sympathetic ne rvous system continue s
to st imulate catecholamine productionand induces the left ventr icular apica l
ballooning typical in TC.
